The Result Arrived After the Decision: Audit Diagnostic Turnaround
November 1, 2026 · 5 min read · Aqrab editorial team
A diagnostic study can report strong accuracy while leaving out a question that matters to its intended use: Will the result reach the decision-maker before the decision? Time spent collecting, transporting, processing, reporting, and acting on a result is not captured by sensitivity or specificity. A technically correct result that arrives too late for the stated decision needs a different role in the care pathway.
Draw the Decision Clock
Imagine a hypothetical service in which the first management decision is made at noon. The times below are invented for teaching, not claims about any real test or service.
| Step | Workflow A | Workflow B |
|---|---|---|
| Specimen collected | 09:00 | 09:00 |
| Result available to clinician | 11:30 | 16:00 |
| First decision | 12:00 | 12:00 |
Even if both workflows had identical diagnostic accuracy, only A could inform the first decision in this example. B might still be useful for a later decision; the timeline alone cannot establish whether either workflow improves patient outcomes. It tells us which decision each result could plausibly inform.
The practical takeaway
For a proposed diagnostic use, put the result time and the decision time on the same timeline. Ask for the proportion of results actually available before that decision, not only the median laboratory processing time.
Five Checks Before Calling a Test “Actionable”
- Name the decision. Is the test meant to guide initial triage, a later review, or follow-up? The deadline depends on that role.
- Start the clock consistently. Is turnaround measured from order, specimen collection, laboratory receipt, or assay start? These are different intervals.
- End the clock at use. A result stored in the laboratory system is not necessarily one seen and acted on by the intended clinician.
- Show the distribution. Report how many results arrived within the decision window and how late the remaining results were; a median can hide slow cases.
- Compare the actual pathway. Include transport, staffing, batching, repeat tests, and communication in the setting where use is proposed.
This is an implementation audit, not a new diagnostic-accuracy statistic. Its answer may change across sites and shifts. A timely result still needs valid accuracy evidence and an evaluated decision pathway before clinical benefit can be claimed.
Where Aqrab Fits
When appraising a diagnostic or clinical-AI study, use Aqrab to separate evidence of accuracy from evidence that results can reach the intended decision in time. A methods critique can identify a missing workflow denominator; it cannot establish local turnaround or patient benefit without those data.
Source Anchors
The WHO Laboratory Quality Stepwise Implementation tool calls for defining turnaround time for laboratory examinations in relation to diagnostic decisions. STARD 2015 asks authors to explain a test’s intended use and clinical role. The FDA statistical guidance frames accuracy estimates around the intended-use population and users. These sources support the audit questions, not the invented timeline above or a claim of clinical benefit.
Keep reading
Don't stop at one method.
Good methods judgment comes from contrast. Read the neighboring guides, see where the assumptions diverge, and avoid treating every observational problem like it needs the same hammer.
Only the Disagreements Were Checked: The Discrepant-Resolution Trap
When a third test checks only disagreements, agreement is not proof that both tests were right. Use this three-question audit before accepting a revised diagnostic-accuracy table.
One Pooled Sensitivity, Two Hospitals: Check Diagnostic Accuracy by Site
A worked two-site example shows how a pooled sensitivity can hide a weaker result in one setting, and what to inspect before transporting a diagnostic claim.
Before the Analyzer: Does Specimen Handling Match Diagnostic Test Use?
A practical specimen-path audit for diagnostic studies: collection, transport, storage, and exclusions can separate the reported accuracy from the intended clinical workflow.